Looking at the Cancer Therapy Market
Cancer is a disease characterized by a population of cells that grow and divide without respect to normal limits, invade and destroy adjacent tissues, and may spread to distant anatomic sites through a process called metastasis. These life-threatening, malignant properties of cancers differentiate them from benign tumors, which are self-limited in their growth and do not invade or metastasize. Cancer may affect people at all ages, but risk for the more common varieties tends to increase with age. It is one of the principal causes of death in developed countries.
Cancer affects everyone – the young and old, the rich and poor, men, women and children – and represents a tremendous burden on patients, families and societies. Cancer is one of the leading causes of death in the world, particularly in developing countries.
Take a look at some hard-hitting facts about this deadly disease:
The report focuses on the leading companies in this segment and what work they are involved in at present in relation to the cancer therapy segment in the global pharmaceutical industry.
Overall, a thorough and complete report looking at the Global Cancer Therapy Market!
Cancer affects everyone – the young and old, the rich and poor, men, women and children – and represents a tremendous burden on patients, families and societies. Cancer is one of the leading causes of death in the world, particularly in developing countries.
Take a look at some hard-hitting facts about this deadly disease:
- In 2005, 7.6 million people died of cancer out of 58 million deaths worldwide.
- More than 70% of all cancer deaths occur in low and middle income countries, where resources available for prevention, diagnosis and treatment of cancer are limited or nonexistent.
- Based on projections, cancer deaths will continue to rise with an estimated 9 million people dying from cancer in 2015, and 11.4 million dying in 2030.
The report focuses on the leading companies in this segment and what work they are involved in at present in relation to the cancer therapy segment in the global pharmaceutical industry.
Overall, a thorough and complete report looking at the Global Cancer Therapy Market!
A. EXECUTIVE SUMMARY
B. INTRODUCTION
B.1 What is Cancer?
B.2 Historical Perspective of the Disease
B.3 Classifying Cancer
B.3.1 Nomenclature
B.3.2 Adult Cancers
B.3.2 Childhood Cancers
C. CAUSES AND PATHOPHYSIOLOGY OF CANCER
C.1 Inciting Events
C.1.1 Chemical Carcinogens
C.1.2 Electromagnetic Radiation
C.1.3 Infectious Diseases
C.1.4 Hormonal Imbalances
C.1.5 Immune System Dysfunction
C.1.6 Heredity
C.1.7 Other Causes
C.2 Looking at Cancer Genetics
C.2.1 Oncogenes
C.2.2 Tumor Suppressor Genes
C.2.3 Types of Genetic Abnormality
C.3 Looking at the Biology of a Cancer Cell
C.3.1 Malignant Progression
C.3.2 Clonal Evolution
C.3.3 Biological Properties
D. DIAGNOSING CANCER & TREATMENT OPTIONS
D.1 Diagnosis
D.1.1 Signs & Symptoms
D.1.2 Biopsy
D.1.3 Cancer Screening
D.2 Treatment of Cancer
D.2.1 Surgery
D.2.2 Radiation Therapy
D.2.3 Chemotherapy
D.2.4 Targeted Therapies
D.2.5 Immunotherapy
D.2.6 Hormonal Therapy
D.2.7 Complementary & Alternative Medicines
D.2.8 Clinical Trials
E. LOOKING AT BRAIN CANCER
E.1 Introduction
E.2 Available Treatments
E.3 Industry Overview
E.4 Industry Growth Drivers
E.5 Market Outlook
F. LOOKING AT BREAST CANCER
F.1 Introduction
F.2 Available Treatments
F.3 Industry Overview
F.4 Industry Growth Drivers
F.5 Market Outlook
G. LOOKING AT LUNG CANCER
G.1 Introduction
G.2 Available Treatments
G.3 Industry Overview
G.4 Industry Growth Drivers
G.5 Market Outlook
H. LOOKING AT LEUKEMIA
H.1 Introduction
H.2 Available Treatments
H.3 Industry Overview
H.4 Industry Growth Drivers
H.5 Market Outlook
I. LOOKING AT PROSTRATE CANCER
I.1 Introduction
I.2 Available Treatments
I.3 Industry Overview
I.4 Industry Growth Drivers
I.5 Market Outlook
J. ANALYZING MAJOR INDUSTRY PLAYERS
J.1 AstraZeneca
J.2 Bristol-Myers Squibb
J.3 GlaxoSmithKline
J.4 Novartis
J.5 Pfizer
J.6 Sanofi Aventis
K. FORECAST FOR THE GLOBAL CANCER MARKET
L. APPENDIX
M. GLOSSARY OF TERMS
B. INTRODUCTION
B.1 What is Cancer?
B.2 Historical Perspective of the Disease
B.3 Classifying Cancer
B.3.1 Nomenclature
B.3.2 Adult Cancers
B.3.2 Childhood Cancers
C. CAUSES AND PATHOPHYSIOLOGY OF CANCER
C.1 Inciting Events
C.1.1 Chemical Carcinogens
C.1.2 Electromagnetic Radiation
C.1.3 Infectious Diseases
C.1.4 Hormonal Imbalances
C.1.5 Immune System Dysfunction
C.1.6 Heredity
C.1.7 Other Causes
C.2 Looking at Cancer Genetics
C.2.1 Oncogenes
C.2.2 Tumor Suppressor Genes
C.2.3 Types of Genetic Abnormality
C.3 Looking at the Biology of a Cancer Cell
C.3.1 Malignant Progression
C.3.2 Clonal Evolution
C.3.3 Biological Properties
D. DIAGNOSING CANCER & TREATMENT OPTIONS
D.1 Diagnosis
D.1.1 Signs & Symptoms
D.1.2 Biopsy
D.1.3 Cancer Screening
D.2 Treatment of Cancer
D.2.1 Surgery
D.2.2 Radiation Therapy
D.2.3 Chemotherapy
D.2.4 Targeted Therapies
D.2.5 Immunotherapy
D.2.6 Hormonal Therapy
D.2.7 Complementary & Alternative Medicines
D.2.8 Clinical Trials
E. LOOKING AT BRAIN CANCER
E.1 Introduction
E.2 Available Treatments
E.3 Industry Overview
E.4 Industry Growth Drivers
E.5 Market Outlook
F. LOOKING AT BREAST CANCER
F.1 Introduction
F.2 Available Treatments
F.3 Industry Overview
F.4 Industry Growth Drivers
F.5 Market Outlook
G. LOOKING AT LUNG CANCER
G.1 Introduction
G.2 Available Treatments
G.3 Industry Overview
G.4 Industry Growth Drivers
G.5 Market Outlook
H. LOOKING AT LEUKEMIA
H.1 Introduction
H.2 Available Treatments
H.3 Industry Overview
H.4 Industry Growth Drivers
H.5 Market Outlook
I. LOOKING AT PROSTRATE CANCER
I.1 Introduction
I.2 Available Treatments
I.3 Industry Overview
I.4 Industry Growth Drivers
I.5 Market Outlook
J. ANALYZING MAJOR INDUSTRY PLAYERS
J.1 AstraZeneca
J.2 Bristol-Myers Squibb
J.3 GlaxoSmithKline
J.4 Novartis
J.5 Pfizer
J.6 Sanofi Aventis
K. FORECAST FOR THE GLOBAL CANCER MARKET
L. APPENDIX
M. GLOSSARY OF TERMS
